Pediatric nonalcoholic fatty liver disease

Gastroenterology Nursing

Volumn 31, Issue 2, 2008, Pages 115-119

  Lerret, Stacee M ^a   Skelton, Joseph A ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL;

ALGORITHM; BARIATRIC SURGERY; BIOPSY; CHILD; DECISION TREE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EARLY DIAGNOSIS; FATTY LIVER; HUMAN; LIFESTYLE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVER TUMOR; NUTRITIONAL DISORDER; OBESITY; ONSET AGE; ORGANIZATION AND MANAGEMENT; PEDIATRIC NURSING; PRENATAL DEVELOPMENT; PREVALENCE; REVIEW; RISK FACTOR;

AGE OF ONSET; ALGORITHMS; BARIATRIC SURGERY; BIOPSY; CHILD; CHILD NUTRITION DISORDERS; DECISION TREES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; EARLY DIAGNOSIS; FATTY LIVER; HUMANS; LIFE STYLE; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; OBESITY; PEDIATRIC NURSING; PREVALENCE; RISK FACTORS; VITAMIN E;

EID: 41949125138     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/01.SGA.0000316530.31366.6e     Document Type: Review

References (24)

1. American Gastroenterological Association. (2002). AGA technical review on nonalcoholic fatty liver disease. Gastroenterology, 123, 1705-1725.
2. Angulo, P. (2006). Nonalcoholic fatty liver disease and liver transplantation. Liver Transplantation, 12, 523-534.
3. Charlton, M., Kasparova, P., Weston, S., Lindor, K. D., Maor-Kendler, Y., Wiesner, R. H., et al. (2001). Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transplantation, 7(7), 608-614.
4. Ford, E. S., Mokdad, A. H., & Ajani, U. A. (2004). Trends in risk factors for cardiovascular disease among children and adolescents in the United States. Pediatrics, 114, 1534-1544.
5. Franzese, A., Vajro, P., Argenziano, A., Puzziello, A., Iannucci, M. P., Saviano, M. C., et al. (1997). Liver involvement in obese children: Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Digestive Diseases & Sciences, 42(7), 1428-1432.
6. Furuya, C. K., de Oliveira, C. P., de Mello, E. S., Faintuch, J., Raskovski, A., Matsuda, M., et al. (2006). Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years. Journal of Gastroenterology & Hepatology, 22(4), 510-514.
7. Hedley, A. A., Ogden, C. L., Johnson, C. L., Carroll, M. D., Curtin, L. R., & Flegal, K. M. (2004). Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA, 291, 2847-2850.
8. Laurin, J., Lindor, K. D., Crippin, J. S., Gossard, A., Gores, G. J., & Ludwig, J. (1996). Ursodeoxycholic acid or clofibrate in the treatment of non-alcoholic induced steatohepatitis: A pilot study. Hepatology, 23, 1464-1467.
9. Lavine, J. E. (2000). Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study. Journal of Pediatrics, 136, 734-738.
10. Lavine, J. E., & Schwimmer, J. B. (2005). NAFLD/NASH in children. In G. C. Farrell, J. George, P. Hall, & A. J. McCullough (Eds.), Fatty liver disease: NASH and related disorders (pp. 229-240). Malden, MA: Blackwell Publishing.
11. McCullough, A. J. (2005). The epidemiology and risk factors of NASH. In G. C. Farrell, J. George, P. Hall, & A. J. McCullough (Eds.), Fatty liver disease: NASH and related disorders (pp. 23-37). Malden, MA: Blackwell Publishing.
12. Neuschwander-Tetri, B. (2005). Nonalcoholic steatohepatitis and the metabolic syndrome. American Journal of the Medical Sciences, 330(6), 326-335.
13. Nobili, V., Marcellini, M., Devito, R., Ciampalini, P., Piemonte, F., Comparcola, D., et al. (2006). NAFLD in children: A prospective clinical-pathological study and effect of lifestyle advice. Hepatology, 44(2), 458-465.
14. Promrat, K., Lutchman, G., Uwaifo, G. I., Freedman, R. J., Soza, A., Heller, T., et al. (2004). A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology, 39(1), 188-196.
15. Ramesh, S., & Sanyal, A. J. (2005). Evaluation and management of non-alcoholic steatohepatitis. Journal of Hepatology, 42, S2-S12.
16. Reddy, J. K., & Rao, M. S. (2006). Lipid metabolism and liver inflammation: II. Fatty liver disease and fatty acid oxidation. American Journal of Physiology: Gastrointestinal & Liver Physiology, 290, G852-G858.
17. Roberts, E. A. (2003). Nonalcoholic steatohepatitis in children. Pediatric Gastroenterology, 5, 253-259.
18. Roberts, E. A., & Yap, J. (2006). Nonalcoholic fatty liver disease (NAFLD): Approach in the adolescent patient. Pediatric Gastroenterology, 9, 423-431.
19. Sanyal, A. J. (2001). Insulin resistance and nonalcoholic steatohepatitis: Fat or fiction? American Journal of Gastroenterology, 96(2), 274-276.
20. Schwimmer, J. B., Behling, C., Newbury, R., Deutsch, R., Nievergelt, C., Schork, N. J., et al. (2005). Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology, 42(3), 641-649.
21. Schwimmer, J. B., Deutsch, R., Kahen, T., Lavine, J. E., Stanley, C., & Behling, C. (2006). Prevalence of fatty liver in children and adolescents. Pediatrics, 118, 1388-1393.
22. Schwimmer, J. B., Middleton, M. S., Deutsch, R., & Lavine, J. E. (2005). A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics, 21, 871-879.
23. Sorof, J. M., Lai, D., Turner, J., Poffenbarger, T., & Portman, R. J. (2004). Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics, 113, 475-482.
24. Tarantino, G., Saldalamacchia, G., Conca, P., & Arena A. (2007). Non-alcoholic fatty liver disease: Further expression of the metabolic syndrome. Journal of Gastroenterology & Hepatology, 22(3), 293-303.